Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity

Yuming Chen,1–3 Jiayi Gu,1–3 Jian Liu,4 Ling Tong,1 Fuxin Shi,5 Xiaoqin Wang,4 Xueling Wang,1–3 Dehong Yu,1–3 Hao Wu1–31Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen Y, Gu J, Liu J, Tong L, Shi F, Wang X, Yu D, Wu H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	silk-polyethyleneglycolhydrogel cisplatin-induced hearing loss dexamethasone round window membrane Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c81583a6698c4bc7a099163660b52a45
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c81583a6698c4bc7a099163660b52a45
record_format	dspace
spelling	oai:doaj.org-article:c81583a6698c4bc7a099163660b52a452021-12-02T06:43:14ZDexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity1178-2013https://doaj.org/article/c81583a6698c4bc7a099163660b52a452019-06-01T00:00:00Zhttps://www.dovepress.com/dexamethasone-loaded-injectable-silk-polyethylene-glycol-hydrogel-alle-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yuming Chen,1–3 Jiayi Gu,1–3 Jian Liu,4 Ling Tong,1 Fuxin Shi,5 Xiaoqin Wang,4 Xueling Wang,1–3 Dehong Yu,1–3 Hao Wu1–31Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, People’s Republic of China; 2Ear Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, People’s Republic of China; 3Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300), Shanghai 200011, People’s Republic of China; 4National Engineering Laboratory for Modern Silk, Soochow University, Suzhou 215123, People’s Republic of China; 5Department of Otology and Laryngology, Eaton-Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Decibel Therapeutics, Boston, MA, 02215, USABackground: Cisplatin is an extensively used anti-neoplastic agent for the treatment of various solid tumors. However, a high incidence of severe ototoxicity is accompanied by its use in the clinic. Currently, no drugs or therapeutic strategies have been approved for the treatment of cisplatin-induced ototoxicity by the FDA.Purpose: The purpose of this study was to investigate the otoprotective effects of dexamethasone (DEX)-loaded silk-polyethylene hydrogel (DEX-SILK) following round window membrane administration in the cisplatin-induced ototoxicity mouse model.Methods: The morphology, gelation kinetics, viscosity and secondary structure of the DEX-SILK hydrogel were analyzed. DEX concentration in the perilymph was tested at different time points following hydrogel injection on the RWM niche. Cultured cells (HEI-OC1), organ of Corti explants (C57/BL6, P0-2), and cisplatin-induced hearing loss mice model (C57/BL6) were used as in vitro and in vivo models for investigating the otoprotective effects of DEX-SILK hydrogel against cisplatin.Results: Encapsulation of DEX with a loading of 8% (w/v) did not significantly change the silk gelation time, and DEX was evenly distributed in the Silk-PEG hydrogel as visualized by scanning electron microscopy (SEM). The concentration of Silk majorly influenced DEX distribution, morphological characteristics, viscosity, and gelation time. The optimized DEX-SILK hydrogel (8% w/v loading, 15% silk concentration, 10 μl) was administered directly onto the RWM of the guinea pigs. The DEX concentration in the perilymph was maintained above 1 μg/ml for at least 21 days for the DEX-SILK, while it was maintained for less than 6 h in the control sample of free DEX. DEX-SILK (5-60 ng/ml) exhibited significant protective effects against cisplatin-induced cellular ototoxicity and notably reduced the production of reactive oxygen species (ROS). Eventually, pretreatment with DEX-SILK effectively preserved outer hair cells in the cultured organ of Corti explants and demonstrated significant hearing protection at 4, 8, and 16 kHz in the cisplatin-induced hearing loss mice as compared to the effects noted following pretreatment with DEX.Conclusion: These results demonstrated the clinical value of DEX-SILK for the therapy of cisplatin-induced ototoxicity.Keywords: silk-polyethyleneglycol hydrogel, cisplatin-induced hearing loss, dexamethasone, round window membraneChen YGu JLiu JTong LShi FWang XWang XYu DWu HDove Medical Pressarticlesilk-polyethyleneglycolhydrogelcisplatin-induced hearing lossdexamethasoneround window membraneMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 4211-4227 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	silk-polyethyleneglycolhydrogel cisplatin-induced hearing loss dexamethasone round window membrane Medicine (General) R5-920
spellingShingle	silk-polyethyleneglycolhydrogel cisplatin-induced hearing loss dexamethasone round window membrane Medicine (General) R5-920 Chen Y Gu J Liu J Tong L Shi F Wang X Wang X Yu D Wu H Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
description	Yuming Chen,1–3 Jiayi Gu,1–3 Jian Liu,4 Ling Tong,1 Fuxin Shi,5 Xiaoqin Wang,4 Xueling Wang,1–3 Dehong Yu,1–3 Hao Wu1–31Department of Otolaryngology-Head and Neck Surgery, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, People’s Republic of China; 2Ear Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, People’s Republic of China; 3Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300), Shanghai 200011, People’s Republic of China; 4National Engineering Laboratory for Modern Silk, Soochow University, Suzhou 215123, People’s Republic of China; 5Department of Otology and Laryngology, Eaton-Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Decibel Therapeutics, Boston, MA, 02215, USABackground: Cisplatin is an extensively used anti-neoplastic agent for the treatment of various solid tumors. However, a high incidence of severe ototoxicity is accompanied by its use in the clinic. Currently, no drugs or therapeutic strategies have been approved for the treatment of cisplatin-induced ototoxicity by the FDA.Purpose: The purpose of this study was to investigate the otoprotective effects of dexamethasone (DEX)-loaded silk-polyethylene hydrogel (DEX-SILK) following round window membrane administration in the cisplatin-induced ototoxicity mouse model.Methods: The morphology, gelation kinetics, viscosity and secondary structure of the DEX-SILK hydrogel were analyzed. DEX concentration in the perilymph was tested at different time points following hydrogel injection on the RWM niche. Cultured cells (HEI-OC1), organ of Corti explants (C57/BL6, P0-2), and cisplatin-induced hearing loss mice model (C57/BL6) were used as in vitro and in vivo models for investigating the otoprotective effects of DEX-SILK hydrogel against cisplatin.Results: Encapsulation of DEX with a loading of 8% (w/v) did not significantly change the silk gelation time, and DEX was evenly distributed in the Silk-PEG hydrogel as visualized by scanning electron microscopy (SEM). The concentration of Silk majorly influenced DEX distribution, morphological characteristics, viscosity, and gelation time. The optimized DEX-SILK hydrogel (8% w/v loading, 15% silk concentration, 10 μl) was administered directly onto the RWM of the guinea pigs. The DEX concentration in the perilymph was maintained above 1 μg/ml for at least 21 days for the DEX-SILK, while it was maintained for less than 6 h in the control sample of free DEX. DEX-SILK (5-60 ng/ml) exhibited significant protective effects against cisplatin-induced cellular ototoxicity and notably reduced the production of reactive oxygen species (ROS). Eventually, pretreatment with DEX-SILK effectively preserved outer hair cells in the cultured organ of Corti explants and demonstrated significant hearing protection at 4, 8, and 16 kHz in the cisplatin-induced hearing loss mice as compared to the effects noted following pretreatment with DEX.Conclusion: These results demonstrated the clinical value of DEX-SILK for the therapy of cisplatin-induced ototoxicity.Keywords: silk-polyethyleneglycol hydrogel, cisplatin-induced hearing loss, dexamethasone, round window membrane
format	article
author	Chen Y Gu J Liu J Tong L Shi F Wang X Wang X Yu D Wu H
author_facet	Chen Y Gu J Liu J Tong L Shi F Wang X Wang X Yu D Wu H
author_sort	Chen Y
title	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
title_short	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
title_full	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
title_fullStr	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
title_full_unstemmed	Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
title_sort	dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/c81583a6698c4bc7a099163660b52a45
work_keys_str_mv	AT cheny dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT guj dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT liuj dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT tongl dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT shif dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT wangx dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT wangx dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT yud dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity AT wuh dexamethasoneloadedinjectablesilkpolyethyleneglycolhydrogelalleviatescisplatininducedototoxicity
_version_	1718399778007547904

Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity

Ejemplares similares